Multiple Myeloma

Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy. In particular, the approval of novel and first-in-class drugs such as thalidomide, bo...

Descripción completa

Detalles Bibliográficos
Clasificación:Libro Electrónico
Autor Corporativo: SpringerLink (Online service)
Otros Autores: Moehler, Thomas (Editor ), Goldschmidt, Hartmut (Editor )
Formato: Electrónico eBook
Idioma:Inglés
Publicado: Berlin, Heidelberg : Springer Berlin Heidelberg : Imprint: Springer, 2011.
Edición:1st ed. 2011.
Colección:Recent Results in Cancer Research, 183
Temas:
Oncology.
Hematology.
Cancer.
Cancer Biology.
Acceso en línea:Texto Completo

MARC

LEADER 00000nam a22000005i 4500
001 978-3-540-85772-3
003 DE-He213
005 20220119232645.0
007 cr nn 008mamaa
008 110420s2011 gw | s |||| 0|eng d
020 |a 9783540857723  |9 978-3-540-85772-3 
024 7 |a 10.1007/978-3-540-85772-3  |2 doi 
050 4 |a RC254-282 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
072 7 |a MJCL  |2 thema 
082 0 4 |a 616.994  |2 23 
245 1 0 |a Multiple Myeloma  |h [electronic resource] /  |c edited by Thomas Moehler, Hartmut Goldschmidt. 
250 |a 1st ed. 2011. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg :  |b Imprint: Springer,  |c 2011. 
300 |a XXIV, 340 p.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Recent Results in Cancer Research,  |x 2197-6767 ;  |v 183 
505 0 |a History and epidemiology -- Pathophysiology: Molecular biology of plasma cell disorders. Alterations in microenvironment -- Clinical Features: Imaging. Integrated innovative approach for diagnosis and staging -- Therapy: High-dose chemotherapy and ABSCT -- Allogeneic transplantation. Novel Drugs -- Immunotherapeutic approaches -- First-line treatment and maintenance -- Relapse -- Radiotherapy -- Kyphoplasty -- Supportive Therapy -- Appendix: Staging and prognosis systems. 
520 |a Multiple myeloma is currently still an incurable disease, but during the past decade knowledge of its molecular pathogenesis has increased rapidly. This has led to remarkable progress in both diagnosis and therapy. In particular, the approval of novel and first-in-class drugs such as thalidomide, bortezomib, and lenalidomide means that multiple myeloma now stands at the forefront of advances in oncology drug development. This book, written by internationally acknowledged experts, covers a wide range of topics relating to multiple myeloma, including history, epidemiology, pathophysiology, clinical features, staging, and prognostic systems. The principal focus, however, is on therapy, with detailed information on the various promising treatment options which give hope that this cancer will be transformed into a chronic disease or even become curable. Individualized therapy and the variety of supportive treatment options, as described in this volume, will help in achieving this goal, as well as in reducing adverse events and improving quality of life. 
650 0 |a Oncology. 
650 0 |a Hematology. 
650 0 |a Cancer. 
650 1 4 |a Oncology. 
650 2 4 |a Hematology. 
650 2 4 |a Cancer Biology. 
700 1 |a Moehler, Thomas.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Goldschmidt, Hartmut.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer Nature eBook 
776 0 8 |i Printed edition:  |z 9783642267994 
776 0 8 |i Printed edition:  |z 9783540858256 
776 0 8 |i Printed edition:  |z 9783540857716 
830 0 |a Recent Results in Cancer Research,  |x 2197-6767 ;  |v 183 
856 4 0 |u https://doi.uam.elogim.com/10.1007/978-3-540-85772-3  |z Texto Completo 
912 |a ZDB-2-SME 
912 |a ZDB-2-SXM 
950 |a Medicine (SpringerNature-11650) 
950 |a Medicine (R0) (SpringerNature-43714) 

Ejemplares similares